Arjo AB (publ) (ARJO-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Arjo AB (publ) (ARJO-B) has a cash flow conversion efficiency ratio of 0.080x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr600.00 Million ≈ $64.57 Million USD) by net assets (Skr7.46 Billion ≈ $802.49 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Arjo AB (publ) defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Arjo AB (publ) - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Arjo AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Arjo AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Arjo AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chengdu KSW Technologies Co. Ltd. A
SHG:688283
|
0.038x |
|
Bintulu Port Holdings Bhd
KLSE:5032
|
0.060x |
|
COMPASS PATHW SP.ADR
F:5Y6
|
0.715x |
|
Union Optech Co Ltd
SHE:300691
|
0.002x |
|
Biotest Aktiengesellschaft
XETRA:BIO3
|
-0.114x |
|
Invesco Municipal Opportunity Trust
NYSE:VMO
|
0.021x |
|
Chapters Group AG
XETRA:CHG
|
0.040x |
|
Hubei Century Network Technology Co Ltd
SHE:300494
|
0.014x |
Annual Cash Flow Conversion Efficiency for Arjo AB (publ) (2014–2025)
The table below shows the annual cash flow conversion efficiency of Arjo AB (publ) from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Arjo AB (publ).
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr7.46 Billion ≈ $802.49 Million |
Skr1.44 Billion ≈ $154.43 Million |
0.192x | +5.84% |
| 2024-12-31 | Skr8.34 Billion ≈ $897.30 Million |
Skr1.52 Billion ≈ $163.15 Million |
0.182x | -33.11% |
| 2023-12-31 | Skr7.58 Billion ≈ $815.94 Million |
Skr2.06 Billion ≈ $221.80 Million |
0.272x | +126.49% |
| 2022-12-31 | Skr7.62 Billion ≈ $820.46 Million |
Skr915.00 Million ≈ $98.47 Million |
0.120x | -52.35% |
| 2021-12-31 | Skr6.88 Billion ≈ $740.94 Million |
Skr1.73 Billion ≈ $186.61 Million |
0.252x | -37.45% |
| 2020-12-31 | Skr5.63 Billion ≈ $605.88 Million |
Skr2.27 Billion ≈ $243.97 Million |
0.403x | +90.20% |
| 2019-12-31 | Skr5.91 Billion ≈ $636.44 Million |
Skr1.25 Billion ≈ $134.74 Million |
0.212x | +15.93% |
| 2018-12-31 | Skr5.43 Billion ≈ $584.03 Million |
Skr991.00 Million ≈ $106.65 Million |
0.183x | +61.98% |
| 2017-12-31 | Skr5.07 Billion ≈ $546.04 Million |
Skr572.00 Million ≈ $61.56 Million |
0.113x | +30.74% |
| 2016-12-31 | Skr10.66 Billion ≈ $1.15 Billion |
Skr919.00 Million ≈ $98.90 Million |
0.086x | +8.73% |
| 2015-12-31 | Skr10.23 Billion ≈ $1.10 Billion |
Skr811.00 Million ≈ $87.28 Million |
0.079x | -12.33% |
| 2014-12-31 | Skr10.60 Billion ≈ $1.14 Billion |
Skr959.00 Million ≈ $103.20 Million |
0.090x | -- |
About Arjo AB (publ)
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and pr… Read more